Approval · Notice of Compliance 38351 · 2026
ANZUPGO: Notice of Compliance 38351
Issued September 24, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38351
- Date
- September 24, 2026
- Company
- Leo Pharma IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New package labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ANZUPGO | Not yet assigned | — |
Medicinal ingredients
- DELGOCITINIB 20 MG per G